Antimicrobial peptides: Application informed by evolution.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 05 11 2018
revised: 25 11 2019
accepted: 09 03 2020
entrez: 2 5 2020
pubmed: 2 5 2020
medline: 19 5 2020
Statut: ppublish

Résumé

Antimicrobial peptides (AMPs) are essential components of immune defenses of multicellular organisms and are currently in development as anti-infective drugs. AMPs have been classically assumed to have broad-spectrum activity and simple kinetics, but recent evidence suggests an unexpected degree of specificity and a high capacity for synergies. Deeper evaluation of the molecular evolution and population genetics of AMP genes reveals more evidence for adaptive maintenance of polymorphism in AMP genes than has previously been appreciated, as well as adaptive loss of AMP activity. AMPs exhibit pharmacodynamic properties that reduce the evolution of resistance in target microbes, and AMPs may synergize with one another and with conventional antibiotics. Both of these properties make AMPs attractive for translational applications. However, if AMPs are to be used clinically, it is crucial to understand their natural biology in order to lessen the risk of collateral harm and avoid the crisis of resistance now facing conventional antibiotics.

Identifiants

pubmed: 32355003
pii: 368/6490/eaau5480
doi: 10.1126/science.aau5480
pmc: PMC8097767
mid: NIHMS1697615
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antimicrobial Cationic Peptides 0
DptA protein, Drosophila 0
Drosophila Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI141385
Pays : United States
Organisme : European Research Council
Pays : International

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

PLoS Pathog. 2014 Oct 09;10(10):e1004445
pubmed: 25299705
Science. 2010 Feb 26;327(5969):1122-6
pubmed: 20185722
Sci Rep. 2016 Nov 07;6:36617
pubmed: 27819351
Philos Trans R Soc Lond B Biol Sci. 2016 May 26;371(1695):
pubmed: 27160603
Trends Microbiol. 2017 Sep;25(9):703-712
pubmed: 28549825
J Biol Chem. 2004 Apr 9;279(15):14853-9
pubmed: 14744858
J Mol Evol. 2007 Nov;65(5):605-15
pubmed: 17938991
Front Immunol. 2019 Nov 08;10:2620
pubmed: 31781114
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11988-E11995
pubmed: 30559213
mBio. 2017 Apr 4;8(2):
pubmed: 28377525
Sci Rep. 2016 Nov 09;6:36692
pubmed: 27827460
Nat Microbiol. 2018 Dec;3(12):1339-1345
pubmed: 30323252
Cell Mol Life Sci. 2017 Feb;74(4):663-682
pubmed: 27557668
Science. 2012 Jul 27;337(6093):477-81
pubmed: 22722251
Nat Genet. 2007 Dec;39(12):1461-8
pubmed: 17987029
Cell Mol Life Sci. 2011 Jul;68(13):2243-54
pubmed: 21560069
PLoS Biol. 2013;11(4):e1001540
pubmed: 23630452
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
Biomaterials. 2013 Jul;34(22):5453-64
pubmed: 23623325
Science. 2007 Jun 22;316(5832):1738-43
pubmed: 17588928
Genome Biol Evol. 2014 Jan;6(1):76-93
pubmed: 24407854
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12590-5
pubmed: 11606746
Genetics. 2001 Oct;159(2):659-71
pubmed: 11606542
Mol Ecol. 2014 Jun;23(12):3000-12
pubmed: 24805928
Sci Transl Med. 2018 Jan 10;10(423):
pubmed: 29321257
PLoS One. 2015 Aug 06;10(8):e0132701
pubmed: 26248029
Dev Comp Immunol. 2012 Mar;36(3):540-6
pubmed: 22001126
PeerJ. 2015 May 21;3:e976
pubmed: 26038731
J Evol Biol. 2005 Nov;18(6):1387-94
pubmed: 16313451
PLoS One. 2013 Oct 18;8(10):e76521
pubmed: 24204634
Elife. 2019 Feb 26;8:
pubmed: 30803481
Philos Trans R Soc Lond B Biol Sci. 2016 May 26;371(1695):
pubmed: 27160593
Microbiology (Reading). 2003 Jun;149(Pt 6):1367-1375
pubmed: 12777478
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14614-9
pubmed: 9405661
Mol Divers. 2006 Nov;10(4):575-84
pubmed: 16969721
Proc Biol Sci. 2018 Mar 14;285(1874):
pubmed: 29540517
Dev Comp Immunol. 2018 Apr;81:193-203
pubmed: 29203331
BMC Evol Biol. 2017 Dec 15;17(1):255
pubmed: 29246101
Proc Biol Sci. 2006 Jan 22;273(1583):251-6
pubmed: 16555795
J Evol Biol. 2010 Dec;23(12):2726-30
pubmed: 21121085
Nature. 2019 Dec;576(7787):452-458
pubmed: 31645764
Clin Microbiol Infect. 2008 Sep;14(9):816-27
pubmed: 18844682
Oncotarget. 2017 Jul 11;8(28):46635-46651
pubmed: 28422728
Nat Rev Microbiol. 2006 Jul;4(7):529-36
pubmed: 16778838
Nucleic Acids Res. 2016 Jan 4;44(D1):D1087-93
pubmed: 26602694
Nat Rev Microbiol. 2006 Jul;4(7):556-62
pubmed: 16778840
Genetics. 1998 Sep;150(1):157-71
pubmed: 9725836
Nat Struct Mol Biol. 2017 Sep;24(9):752-757
pubmed: 28741611
Nat Ecol Evol. 2017 Aug;1(8):1160-1167
pubmed: 29046583
Sci Rep. 2017 Oct 13;7(1):13153
pubmed: 29030606
Insect Biochem Mol Biol. 2019 Jul;110:60-68
pubmed: 31051236
Philos Trans R Soc Lond B Biol Sci. 2016 May 26;371(1695):
pubmed: 27160596
J Mol Biol. 2016 Aug 28;428(17):3355-71
pubmed: 27170548
Sci Rep. 2019 Mar 4;9(1):3331
pubmed: 30833614
Nat Microbiol. 2019 Mar;4(3):447-458
pubmed: 30559406
Lancet Infect Dis. 2016 Feb;16(2):239-51
pubmed: 26795692
J Biomed Biotechnol. 2009;2009:315423
pubmed: 19888430
Evol Appl. 2014 Sep;7(8):905-12
pubmed: 25469169
EBioMedicine. 2015 Jun 10;2(7):690-8
pubmed: 26288841
Science. 2011 Oct 21;334(6054):362-5
pubmed: 22021855
Science. 2012 Aug 31;337(6098):1107-11
pubmed: 22936781
Antimicrob Agents Chemother. 2016 Jan 04;60(3):1717-24
pubmed: 26729502
Science. 2015 Jan 9;347(6218):170-5
pubmed: 25574022
Philos Trans R Soc Lond B Biol Sci. 2016 May 26;371(1695):
pubmed: 27160595
Nat Rev Immunol. 2016 May;16(5):321-34
pubmed: 27087664
mBio. 2019 Oct 22;10(5):
pubmed: 31641083
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
J Biol Chem. 2014 Mar 28;289(13):9172-81
pubmed: 24558045
Curr Opin Microbiol. 2008 Jun;11(3):284-9
pubmed: 18555739
Genome Biol. 2008;9(9):R143
pubmed: 18817538
Sci Transl Med. 2013 Sep 25;5(204):204ra132
pubmed: 24068739
Nat Commun. 2016 Oct 03;7:13002
pubmed: 27694971
Nat Rev Microbiol. 2011 May;9(5):356-68
pubmed: 21423246
Pharmacol Rev. 1995 Jun;47(2):331-85
pubmed: 7568331
Antimicrob Agents Chemother. 2001 May;45(5):1558-60
pubmed: 11302828
Proc Biol Sci. 2015 May 7;282(1806):20150293
pubmed: 25833860
Mol Ecol. 2017 Oct;26(19):5334-5343
pubmed: 28762573
Nat Nanotechnol. 2010 Apr;5(4):280-5
pubmed: 20228787
Evolution. 2015 Feb;69(2):431-46
pubmed: 25403856
Genome Biol Evol. 2019 Sep 1;11(9):2691-2701
pubmed: 31504505
PLoS Pathog. 2011 Jul;7(7):e1002158
pubmed: 21811410
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):E3730-8
pubmed: 24003149
J Antimicrob Chemother. 2017 Jan;72(1):115-127
pubmed: 27650186
Microb Biotechnol. 2018 Nov;11(6):1027-1036
pubmed: 29488347
Nat Microbiol. 2018 Jun;3(6):718-731
pubmed: 29795541
Eur J Biochem. 1995 Mar 1;228(2):257-64
pubmed: 7705337
Curr Biol. 2016 Jan 25;26(2):257-262
pubmed: 26776733
Plant Physiol. 1995 Aug;108(4):1353-8
pubmed: 7659744
Nature. 2002 Jan 24;415(6870):389-95
pubmed: 11807545
Nat Commun. 2019 Oct 4;10(1):4538
pubmed: 31586049
Nucleic Acids Res. 2016 Mar 18;44(5):2439-50
pubmed: 26809677
Philos Trans R Soc Lond B Biol Sci. 2016 May 26;371(1695):
pubmed: 27160594
mBio. 2017 Aug 1;8(4):
pubmed: 28765224
Mol Immunol. 2009 Feb;46(4):516-22
pubmed: 18962895
Mol Biol Evol. 2016 Dec;33(12):3075-3087
pubmed: 27524825
PLoS Genet. 2006 Apr;2(4):e64
pubmed: 16683038
J Exp Bot. 2018 Oct 12;69(21):4997-5011
pubmed: 30099553

Auteurs

Brian P Lazzaro (BP)

Department of Entomology, Cornell Institute of Host-Microbe Interactions and Disease, Cornell University, Ithaca, NY, USA.

Michael Zasloff (M)

MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC, USA.

Jens Rolff (J)

Freie Universität Berlin, Evolutionary Biology, Institut für Biologie, Königin-Luise-Strasse 1-3, 14195 Berlin, Germany. jens.rolff@fu-berlin.de.
Berlin-Brandenburg Institute of Advanced Biodiversity Research (BBIB), 14195 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH